One issue that often is overlooked is the importance of sexual intimacy. It may be surprising to know that approximately 40 million American women suffer from some type of sexual disorder — the most common being Hypoactive Sexual Desire Disorder (HSDD), sometimes referred to as low sex drive.
BioSante Pharmaceuti-cals, Inc. is currently sponsoring a nationwide medical research study, the Bloom Study, to determine if LibiGel®, an investigational study medication, can increase women’s sexual desire.
“We know there is a tremendous medical need to address women suffering with low sexual desire,” said James A. Simon, MD, a LibiGel study investigator, clinical professor of Obstetrics and Gynecology at the George Washington University in Washington, DC, medical director at The Women’s Health Research Center in Laurel, Maryland and past president of the North American Menopause Society. “Currently, there are no medications approved by the US Food and Drug Administration (FDA) for the treatment of low sexual desire.”
Sexual activity has many health benefits and is an important part of relationships. But those with HSDD are rarely in the mood for intimacy. For women who have gone through menopause either naturally or after surgery, a decrease in the production of natural testosterone may occur. Testosterone is a hormone that affects many things, including sex drive. The reduction in testosterone may contribute to the symptoms of HSDD, a common condition defined as the persistent lack of sexual desire. And this decrease in sex drive can result in personal distress and interpersonal problems.
The Bloom Study is currently looking for Brooklyn area women at least 30 years of age who have lost their sex drive. Qualified participants must have either gone through menopause or had their ovaries removed. The study is examining the safety and effectiveness of the investigational medication, LibiGel, for the treatment of HSDD. The investigational medication is applied daily to the skin on a woman’s upper arm.
The Bloom Study is taking place in Brooklyn and other cities across the United States. For more on the Bloom Study, visit www.bloomstudy.com or call 1-877-BLOOM-81.